Merck Announces Third-Quarter 2018 Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/26/2026
- S&P 500, Nasdaq set for weekly fall as chip stocks slide
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
- Needham Starts NeoVolta (NEOV) at Buy
- TD Cowen: 'Sober View Suggests Structural Alcohol Risks Are Overblown'
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
Goldman Sachs Says Merck (MRK) 'Likely to be the Dominant Player in All of NSCLC'
May 23, 2018 9:26 AM EDTMerck (NYSE: MRK) announced that its phase 3 trial in 1L squamous NSCLC, KN-407 met its dual primary endpoint of OS and PFS based on an interim analysis conducted by the DMC. Goldman Sachs expects full data at ASCO and anticipated this update after... More
